tiprankstipranks
Trending News
More News >
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Ratios

Compare
1,605 Followers

Perspective Therapeutics Ratios

CATX's free cash flow for Q3 2025 was $-2.71. For the 2025 fiscal year, CATX's free cash flow was decreased by $ and operating cash flow was $-123.94. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Jun 22
Liquidity Ratios
Current Ratio
5.17 5.17 12.68 1.07 19.89
Quick Ratio
5.17 5.17 12.68 1.07 19.36
Cash Ratio
1.07 1.07 3.38 0.59 7.84
Solvency Ratio
-1.68 -1.72 -1.57 -2.00 -4.15
Operating Cash Flow Ratio
-2.38 -2.88 -1.00 -2.36 -4.55
Short-Term Operating Cash Flow Coverage
-109.78 -132.40 -351.81 -753.33 0.00
Net Current Asset Value
$ 88.45M$ 88.45M$ 180.73M$ -5.88M$ 49.77M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.01 0.03 0.00
Debt-to-Equity Ratio
<0.01 <0.01 0.01 0.03 0.00
Debt-to-Capital Ratio
<0.01 <0.01 0.01 0.03 0.00
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.02 0.00
Financial Leverage Ratio
1.29 1.29 1.17 1.30 1.06
Debt Service Coverage Ratio
-70.32 40.20 3.14K -280.52 0.00
Interest Coverage Ratio
36.84 -24.30 -217.90 -487.39 0.00
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 0.00
Interest Debt Per Share
0.03 0.02 0.06 0.05 0.00
Net Debt to EBITDA
0.47 -3.17 -5.50 0.17 1.41
Profitability Margins
Gross Profit Margin
-166.35%0.00%0.00%100.00%23.00%
EBIT Margin
-7827.94%0.00%0.00%-2855.02%-213.71%
EBITDA Margin
-7377.41%0.00%0.00%-2786.61%-208.87%
Operating Profit Margin
1086.33%0.00%0.00%-2855.02%-213.71%
Pretax Profit Margin
-12356.00%0.00%0.00%-2796.79%-206.50%
Net Profit Margin
-12261.71%0.00%0.00%-3243.24%-206.50%
Continuous Operations Profit Margin
-12261.71%0.00%0.00%-2611.92%-206.50%
Net Income Per EBT
99.24%99.24%97.42%115.96%100.00%
EBT Per EBIT
-1137.41%-1137.41%-778.05%97.96%96.63%
Return on Assets (ROA)
-38.63%-38.63%-23.24%-47.51%-25.25%
Return on Equity (ROE)
-41.27%-49.81%-27.27%-61.86%-26.85%
Return on Capital Employed (ROCE)
3.83%3.83%3.24%-49.79%-27.40%
Return on Invested Capital (ROIC)
3.79%3.79%3.15%-46.45%-28.73%
Return on Tangible Assets
-45.43%-45.43%-27.23%-198.12%-25.29%
Earnings Yield
-26.76%-50.80%-38.58%-21.07%-10.82%
Efficiency Ratios
Receivables Turnover
140.17 0.00 0.00 1.22 5.21
Payables Turnover
0.00 0.00 0.00 0.00 3.55
Inventory Turnover
0.00 0.00 0.00 0.00 3.88
Fixed Asset Turnover
0.01 0.00 0.00 0.23 3.45
Asset Turnover
<0.01 0.00 0.00 0.01 0.12
Working Capital Turnover Ratio
<0.01 0.00 0.00 0.06 0.13
Cash Conversion Cycle
2.60 0.00 0.00 299.08 61.22
Days of Sales Outstanding
2.60 0.00 0.00 299.08 70.03
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 94.02
Days of Payables Outstanding
0.00 0.00 0.00 0.00 102.83
Operating Cycle
2.60 0.00 0.00 299.08 164.05
Cash Flow Ratios
Operating Cash Flow Per Share
-0.93 -1.12 -0.28 -0.67 -0.22
Free Cash Flow Per Share
-1.03 -1.29 -1.13 -0.69 -0.23
CapEx Per Share
0.11 0.17 0.84 0.02 <0.01
Free Cash Flow to Operating Cash Flow
1.12 1.15 3.97 1.03 1.02
Dividend Paid and CapEx Coverage Ratio
-8.62 -6.47 -0.34 -34.43 -40.30
Capital Expenditure Coverage Ratio
-8.62 -6.47 -0.34 -34.43 -40.30
Operating Cash Flow Coverage Ratio
-42.01 -50.67 -4.50 -14.47 0.00
Operating Cash Flow to Sales Ratio
-81.32 0.00 0.00 -25.74 -1.71
Free Cash Flow Yield
-19.68%-46.92%-35.38%-17.21%-9.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.74 -1.97 -2.59 -4.75 -9.24
Price-to-Sales (P/S) Ratio
461.31 0.00 0.00 153.92 19.09
Price-to-Book (P/B) Ratio
1.86 0.98 0.71 2.94 2.48
Price-to-Free Cash Flow (P/FCF) Ratio
-5.08 -2.13 -2.83 -5.81 -10.87
Price-to-Operating Cash Flow Ratio
-5.63 -2.46 -11.23 -5.98 -11.14
Price-to-Earnings Growth (PEG) Ratio
-0.92 -0.14 -0.06 -0.02 -0.09
Price-to-Fair Value
1.86 0.98 0.71 2.94 2.48
Enterprise Value Multiple
-5.79 19.04 14.15 -5.36 -7.73
Enterprise Value
358.96M 173.98M 148.00M 214.03M 114.62M
EV to EBITDA
-5.79 19.04 14.15 -5.36 -7.73
EV to Sales
426.83 0.00 0.00 149.26 16.14
EV to Free Cash Flow
-4.70 -1.83 -2.04 -5.63 -9.19
EV to Operating Cash Flow
-5.25 -2.11 -8.09 -5.80 -9.42
Tangible Book Value Per Share
2.26 2.26 3.74 0.01 0.99
Shareholders’ Equity Per Share
2.80 2.80 4.51 1.37 1.00
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 0.03 0.07 0.00
Revenue Per Share
0.01 0.00 0.00 0.03 0.13
Net Income Per Share
-1.40 -1.40 -1.23 -0.85 -0.27
Tax Burden
0.99 0.99 0.97 1.16 1.00
Interest Burden
1.58 0.00 1.00 0.98 0.97
Research & Development to Revenue
94.85 0.00 0.00 14.86 0.37
SG&A to Revenue
35.95 0.00 0.00 14.62 1.53
Stock-Based Compensation to Revenue
5.31 0.00 0.00 2.61 0.19
Income Quality
0.62 0.80 0.23 0.79 0.83
Currency in USD